F-group (family)
298.1.1.10 DXP_redisom_C
Ligands and drugs
595
Member domains
169
with ligand contacts (≤ 4 Å)
28.4% of members
136
with DrugDomain annotations
22.9% of members
104
with a DrugBank compound
17.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 298.1.1.10 belongs to X-group 298 FwdE/GAPDH domain-like, which binds 8.0 ligand superclasses per 20 proteins, broader than 56% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02338 | NDP | NADPH | 60 |
| DB02948 | FOM | Fosmidomycin | 27 |
| DB03309 | NHE | N-cyclohexyltaurine | 4 |
| DB02496 | DXP | 1-Deoxy-D-xylulose 5-phosphate | 2 |
| DB03649 | CBQ | [{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate | 2 |
| DB14128 | NAD | Nadide | 2 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| MNmetal | MANGANESE (II) ION | 92 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 77 |
| CAmetal | CALCIUM ION | 30 |
| FOM | 3-[FORMYL(HYDROXY)AMINO]PROPYLPHOSPHONIC ACID | 29 |
| MGmetal | MAGNESIUM ION | 28 |
| CL | CHLORIDE ION | 6 |
| F98 | 3-[ethanoyl(hydroxy)amino]propylphosphonic acid | 5 |
| A1L41 | [(1~{S})-4-oxidanylidene-4-[oxidanyl(4-phenylbutyl)amino]-1-phenyl-butyl]phosphonic acid | 4 |
| A1L43 | [(1~{S})-4-oxidanylidene-4-[oxidanyl(5-phenylpentyl)amino]-1-phenyl-butyl]phosphonic acid | 4 |
| A1L4W | [(1~{S})-4-oxidanylidene-4-[oxidanyl(2-phenylethyl)amino]-1-phenyl-butyl]phosphonic acid | 4 |
| NHE | 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID | 4 |
| UW0 | [(1~{S})-4-oxidanylidene-4-[oxidanyl(3-phenylpropyl)amino]-1-phenyl-butyl]phosphonic acid | 4 |
| FM5 | 3-(N-HYDROXYACETAMIDO)-1-(3,4-DICHLOROPHENYL)PROPYLPHOSPHONIC ACID | 3 |
| FM6 | [(1S)-1-(3,4-dichlorophenyl)-3-[oxidanyl(phenylcarbonyl)amino]propyl]phosphonic acid | 3 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 3 |
| 1UQ | [(S)-({2-[hydroxy(methyl)amino]-2-oxoethyl}sulfanyl)(phenyl)methyl]phosphonic acid | 2 |
| 34F | (1S)-1-(3,4-DICHLOROPHENYL)-3-[FORMYL(HYDROXY)AMINO]PROPYL}PHOSPHONIC ACID | 2 |
| 48S | [(2R)-4-[hydroxy(methyl)amino]-2-(4-methylphenyl)-4-oxobutyl]phosphonic acid | 2 |
| 6J8 | [(2R)-2-{2-[hydroxy(methyl)amino]-2-oxoethyl}-5-(4-methoxyphenyl)pentyl]phosphonic acid | 2 |
| 6JB | [(2R)-2-{2-[hydroxy(methyl)amino]-2-oxoethyl}-5-(3-methoxyphenyl)pentyl]phosphonic acid | 2 |